What Motus Nova does

Motus Nova, LLC is an Atlanta-based healthcare robotics company founded in 2013 that designs, manufactures, and distributes FDA Class 1 cleared robotic exoskeletons for home-based rehabilitation of stroke and brain injury survivors. The company's core products, the Motus Hand (upper extremity) and Motus Foot (lower extremity), use a proprietary pneumatic pump-based active-assistive mechanism to extend or flex the user's hand or foot during therapy sessions, replicating therapist assistance in a home setting. Each device is paired with a 22–23 inch touchscreen monitor that runs gamified therapy exercises (10 games) with real-time biofeedback, and integrates built-in movement sensors that track range of motion, repetitions, and session data. A telehealth platform enables remote clinical specialists to monitor progress and conduct video consultations.

The company operates a direct-to-consumer subscription model, shipping devices directly to patient homes across all 50 U.S. states with no long-term commitment (devices are returned when rehabilitation goals are met). Reimbursement is handled through Medicare and most major private insurers, with the company managing billing and appeals directly; patients are responsible for co-pays and deductibles, and financial hardship assistance is available. The GTM motion combines inbound phone/website leads, outbound calling, clinic referrals, and an active Facebook support community, supported by earned media coverage in TIME, NPR, FOX, NBC, CBS, and Washington Post. Scientific credibility is anchored by 24 peer-reviewed publications and scientific advisors from Emory University, UAB, Yale, the VA Healthcare System, and the Marcus Stroke and Neuroscience Center at Grady Hospital.

As of 2023, devices had been deployed in 3,000+ homes nationwide. Clinical studies at Emory and VA hospitals reported 82% functional improvement among users after a few months of use, outcomes equivalent to therapist-led rehabilitation in randomized trials, and a 55–65% cost reduction versus traditional outpatient therapy. The company employs 11–50 people, is privately held with no disclosed external venture funding, and is led by CEO David Wu and Chairman Stacy Kenworthy. Corporate advisors include the former CEO of P&G International and a former advisor to the CDC Director.

Name

Motus Nova

Legal name

Motus Nova, LLC

Website

https://motusnova.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Motus Nova is an Atlanta-based healthcare robotics company that sells FDA Class 1 cleared, pneumatic-powered Motus Hand and Motus Foot robotic exoskeletons on a subscription basis, shipped directly to stroke and brain injury survivors' homes across all 50 U.S. states with insurance reimbursement.

Ownership category

akta.pro rank

Product category

Rehabilitation Robotics

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Medical Equipment and Supplies Manufacturing (3391)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industries

Assistive Technology, Adaptive Equipment & Home Exercise Program Training In-Home (HSABADAN), Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC), Prosthetics/Orthotics Rehab & Amputee Rehabilitation (HSADAIAN)

Keywords

• Robotic rehabilitation devices
• Stroke rehabilitation therapy
• Neurorehabilitation technology
• Home medical equipment
• Telerehabilitation services

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Subscription Services: Monthly subscription model for at-home robotic rehabilitation devices (Motus Hand and Motus Foot). Devices include touchscreen monitor, technical and clinical support, software updates, personalized reports, and therapy. No long-term commitment - users can return devices upon reaching rehabilitation goals.
2. Insurance Reimbursement: Services covered by Medicare and most major private insurance plans. Company handles billing directly with insurers including appeals for denied authorizations. Patients responsible for co-pays, deductibles, and coinsurance.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Motus Nova designs, manufactures, and delivers FDA Class 1 cleared robotic exoskeleton devices—Motus Hand for upper extremity and Motus Foot for lower extremity—for at-home stroke and brain injury rehabilitation. Devices are offered on a monthly subscription with a paired 22-inch touchscreen monitor running gamified therapy exercises and a telehealth platform that enables remote clinical monitoring, while the company handles direct billing to Medicare and major private insurers.

Product overview

Motus Nova offers a unified home-based stroke rehabilitation system consisting of two FDA Class 1 cleared robotic devices—the Motus Hand for upper extremity rehabilitation and Motus Foot for lower extremity rehabilitation—paired with a touchscreen monitor displaying gamified therapy exercises and a telehealth platform for remote clinical oversight. The system uses active-assistive pneumatic technology and built-in movement sensors to provide automated therapeutic assistance, real-time biofeedback, and progress tracking. Users receive the device(s) via mail with setup instructions, along with access to clinical specialists, software updates, and personalized therapy reports. The portfolio includes clinical studies supporting efficacy and a subscription-based pricing model with insurance coverage including Medicare.

Differentiator

Problem solved

Functional benefit

Brands

• Motus Hand: Upper extremity rehabilitation device for hand therapy
• Motus Foot
• Hand Mentor
• Foot Mentor
• Hand Mentor Pro
• Foot Mentor Pro
• Home Mentor System

Products and services

• Motus Hand FDA Class 1 cleared upper extremity rehabilitation robot designed for at-home use by stroke and brain injury survivors. Provides active-assistive hand therapy with gamified exercises on a connected touchscreen monitor, using a pneumatic pump system for users with limited or no movement and built-in sensors to track repetitions, range of motion, and progress.
• Motus Foot FDA Class 1 cleared lower extremity rehabilitation robot for at-home use by stroke survivors. Provides active-assistive foot and ankle therapy to improve walking speed, distance, and dorsiflexion force, with gamified exercises on a touchscreen monitor and built-in movement sensors to track rehabilitation progress.
• Hand & Foot Mentor Pro (Clinical Version) Hospital-grade predecessor robotic devices for upper and lower extremity rehabilitation, deployed in approximately 200 clinics nationwide at over $25,000 per unit. Served as the clinical foundation that later informed the home-based Motus Hand and Motus Foot products.
• Telehealth Platform and Clinical Specialist Support Remote clinical monitoring and support service bundled with Motus Hand and Foot subscriptions. Enables clinicians to deliver post-stroke rehabilitation via telehealth, monitor patient progress through device-generated data, conduct onboarding and check-in appointments with therapy specialists, and support enrollment and onboarding.

Quantifiable outcome

• 82% of users report functional improvement after a few months of use
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• University of Alabama at Birmingham (UAB)coreStrategic or Co-development PartnerAcademic partnership for research and clinical validation. UAB School of Health Professions Dean Dr. Andrew Butler serves as Scientific Advisor. Partnership mentioned in Privacy Policy for sharing de-identified information. Collaboration on tele-rehabilitation robotics deployment.
• Emory UniversitycoreStrategic or Co-development PartnerLong-standing research partnership with Emory School of Medicine. Dr. Steven Wolf, Professor in Department of Rehabilitation Medicine, serves as Scientific Advisor. Clinical studies conducted at Emory and VA hospitals demonstrating device efficacy. Origin of technology development.
• NCHPAD (National Center on Health, Physical Activity, and Disability)minorStrategic or Co-development PartnerListed as subsidiary/affiliate in Privacy Policy. Organization focused on health and disability resources, potentially supporting marketing and patient outreach efforts.
• VA (Veterans Affairs) Healthcare SystemcoreStrategic or Co-development PartnerClinical studies conducted at VA hospitals demonstrating home-based rehabilitation outcomes. Research published on cost-effective home-based rehabilitation for rural veteran stroke survivors (65% cost reduction). Multiple peer-reviewed publications from VA collaboration.
• Marcus Stroke and Neuroscience Center at Grady HospitalminorStrategic or Co-development PartnerDr. Samir Belagaje serves as Scientific Advisor and is Director of Rehabilitation at the Marcus Stroke and Neuroscience Center. Clinical collaboration for stroke rehabilitation research.
• Yale University School of MedicineminorStrategic or Co-development PartnerDr. Xuan Luo serves as Scientific Advisor; Assistant Professor of Orthopedics and Rehabilitation with special interest in hand and upper extremity conditions including post-stroke arthritis.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Saebo: Specializes in affordable upper extremity rehabilitation products for stroke survivors (SaeboGlove, SaeboReach, SaeboStretch). Direct competitor targeting the same at-home stroke rehab market with lower-cost, non-robotic orthotic solutions.
• Tyromotion: Austrian manufacturer of robotic and sensor-based rehabilitation devices (Diego, Pablo, Amadeo) for upper extremity therapy. Comparable product portfolio for clinical neurorehabilitation, though primarily hospital/clinic positioning.
• Bionik Laboratories: Robotic rehabilitation company with InMotion ARM and InMotion ARM/HAND systems for upper extremity stroke rehab. Direct competitor in clinical robotic therapy, recently expanding into home and tele-rehabilitation markets.
• Flint Rehab: Developer of low-cost home rehabilitation devices (MusicGlove, FitMi) for stroke survivors. Directly comparable at-home rehabilitation focus with consumer-friendly pricing and gamified therapy approach.
• Ekso Bionics: Developer of exoskeleton robotics for rehabilitation and mobility assistance. Public company with FDA-cleared EksoNR for stroke rehab; competes in neurorehabilitation robotics with overlapping clinical evidence and hospital positioning.
• Hocoma (DIH Technology): Global leader in robotic and sensor-based rehabilitation devices for stroke and neurological conditions. Offers Armeo (upper extremity) and Lokomat (gait) products; directly comparable to Motus Hand and Foot, though primarily clinical setting vs. Motus's at-home focus.

Broad incumbents

• ReWalk Robotics: Public company developing wearable robotic exoskeletons for spinal cord injury and stroke mobility. Broader exoskeleton player with overlapping rehabilitation focus but primarily lower extremity gait applications.
• Parker Hannifin (Indego): Industrial conglomerate with Indego powered exoskeleton for clinical and personal use in stroke and spinal cord injury rehabilitation. Established large player entering the same rehab robotics market.

Emerging players

• MindMaze: Digital neurotherapeutics platform combining VR, AI, and brain-computer interfaces for stroke and brain injury recovery. Emerging player with overlapping telehealth and gamified rehab approach but different core technology.
• Neurolutions (IpsiHand): Developer of the IpsiHand, an FDA-cleared EEG-controlled robotic hand exoskeleton for chronic stroke rehabilitation. Closely comparable at-home robotic upper extremity device with overlapping target patient population.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/groups/2726418487598731
• Xx.com/motusnova
• LinkedInlinkedin.com/company/motusnova

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Motus Nova